
Robert Barrow
Chief Executive Officer and Board Director


Miri Halperin Wernli, PhD
Executive President and Board Director


Cynthia Hu, JD
Chief Legal Officer & Corporate Secretary


Daniel Karlin, MD, MA
Chief Medical Officer


Schond Greenway, MBA
Chief Financial Officer


Francois Lilienthal, MD, MBA
Chief Commercial Officer


Robert Silva, PhD
VP, Head of Development


Robert Malenka, MD, PhD
Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University


Peter Bergethon, MD
Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.


Robert Dworkin, PhD
Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester


Maurizio Fava, MD
Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)


Maria Oquendo, MD, PhD
Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania


Bridget Walton, MS
VP, Global Regulatory Affairs


Kenneth Alper, MD
Clinical Associate Professor of Psychiatry and Neurology at the New York University School of Medicine


Peter Gasser, MD
Clinical Advisor


Stanley D Glick, MD PhD
Scientific Advisor


Matthew W Johnson, PhD
Clinical Advisor


Kim PC Kuypers, PhD
Scientific Collaborator & Advisor


Matthias Liechti, MD, PhD
Scientific Collaborator & Advisor


Carol Vallone
Chair of the Board of Directors, Chair of Compensation Committee, Member of Audit/Finance Committee


Natalie Wheeler, PhD
Medical Science Liaison with Dova Pharmaceuticals


John Rotrosen, MD
Professor of Psychiatry with New York University’s Langone’s Department of Psychiatry


Andreas Krebs
Vice Chair of the Board of Directors, Chair of Nomination and Governance Committee, Member of Audit/Finance Committee


Brigid Makes
Board Director, Chair of Audit/Finance Committee, Member of Compensation Committee, Member of Nomination and Governance Committee


Carrie Liao, CPA
VP, Corporate Controller & Principal Accounting Officer


Peter Mack, PhD
VP, Pharmaceutical Development


Carole Abel, MBA
VP, Programs and Portfolio Office (PPO)
